Research Article
Target Based Designing of Anthracenone Derivatives as Tubulin Polymerization Inhibiting Agents: 3D QSAR and Docking Approach
Table 4
Docking summary for the selected eligible anthracenone derivatives.
| CPD | IPT IC50 (M) | Binding energy (kcal/mol) | Ki predicted activity | Torsional energy (kcal/mol) | H-bonding “residue” |
| 16c | 0.36 | −8.26 | 882.37 nM | 0.89 | Ser-140 | | | | | | Gln-247 | 16f | 1.60 | −8.22 | 945.09 nM | 0.89 | Asp-251 | 16h | 0.36 | −8.07 | 1.22 uM | 1.19 | Asn-101 | 20c | 0.69 | −8.73 | 398.87 nM | 0.6 | Asn-258 | 20i | 0.42 | −8.80 | 351.79 nM | 0.89 | Val-181 | 31a | 1.70 | −8.62 | 482.67 nM | 0.6 | — | | | | | | (only polar interactions) | 31b | 0.53 | −8.91 | 293.25 nM | 0.89 | Val-238 | 31c | 0.69 | −8.98 | 259.6 nM | 0.89 | Val-181 NH | 31d | 0.69 | −8.16 | 1.04 uM | 1.19 | Asn-101 | | | | | | Ser-178 | 31e | 0.36 | −7.91 | 1.6 uM | 1.49 | Asn-101 | | | | | | Ser-178 | Colchicine | 1.40 | −9.47 | 114.73 nM | 1.79 | Val-181 | | | | | | Asn-101 |
|
|